|
|
Volumn 348, Issue 20, 2003, Pages 1948-1951
|
|
SARS-associated coronavirus
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INACTIVATED VACCINE;
MESSENGER RNA;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE;
VIRULENCE FACTOR;
VIRUS GLYCOPROTEIN;
VIRUS RNA;
VIRUS VACCINE;
COMMON COLD;
CONVALESCENCE;
CORONAVIRUS;
DRUG TARGETING;
GENE DELETION;
GENE INSERTION;
GENETIC CODE;
HOST PATHOGEN INTERACTION;
HUMAN;
IMMUNE RESPONSE;
INFECTION CONTROL;
INFECTION RISK;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
PROTEIN BINDING;
REVIEW;
SEROLOGY;
SEVERE ACUTE RESPIRATORY SYNDROME;
VIRUS GENOME;
VIRUS IDENTIFICATION;
VIRUS MORPHOLOGY;
VIRUS NUCLEOCAPSID;
VIRUS PATHOGENESIS;
VIRUS PNEUMONIA;
VIRUS REPLICATION;
ANIMAL DISEASES;
ANIMALS;
CORONAVIRUS;
DISEASE OUTBREAKS;
GENOME, VIRAL;
HUMANS;
MUTATION;
SARS VIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
VIRAL VACCINES;
VIRION;
VIRULENCE;
|
|
EID: 0038326554
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp030078 Document Type: Review |
|
Times cited : (290)
|
|
References (1)
|
